Zidovudine
Retrovir (zidovudine) is an oral capsule medication containing 100 mg of zidovudine, used to treat HIV infection by inhibiting the virus's ability to replicate in the body. Manufactured by ViiV Healthcare Company, it's a prescription drug approved under NDA019655. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Retrovir (zidovudine) is an oral capsule medication containing 100 mg of zidovudine, used to treat HIV infection by inhibiting the virus's ability to replicate in the body. Manufactured by ViiV Healthcare Company, it's a prescription drug approved under NDA019655. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Zidovudine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Zidovudine — ANDA 019910 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019910"
}
]
|
| identifier | ANDA019910 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"health-care",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Zidovudine |
